| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Sep-08 | | Total Revenue | 6,617 | 7,064 | 7,278 | 11,213 | | Cost of Revenue |
-
|
-
|
-
| 998 | | | Gross Profit | 6,617 | 7,064 | 7,278 | 10,215 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,508 | 3,767 | 4,042 | 13,340 | | Non Recurring | 597 | 1,711 | 569 | 939 | | Others | 2,693 | 2,433 | 2,715 | 1,899 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,066 | (847) | (48) | (5,963) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,569 | 4,088 | 1,854 | 1,257 | | Earnings Before Interest And Taxes | 2,371 | 3,241 | 1,806 | (4,706) | | Interest Expense | 509 | 417 | 395 | 350 | | Income Before Tax | 1,862 | 2,824 | 1,411 | (5,056) | | Income Tax Expense | (426) | 4 | 386 | 2,393 | | Minority Interest |
-
|
-
|
-
| 1,728 | | | | Net Income From Continuing Ops | 2,288 | 2,820 | 1,025 | (5,721) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,288 | 2,820 | 1,025 | (5,721) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,288 | $2,820 | $1,025 | ($5,721) |
|
0.02% Nasdaq 0.00%
Income Statement
